Home > Boards > Free Zone > User's Groups > FDA Plays

Medicare pays for REPR's product and rejects everybody

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Rawnoc Member Profile Rawnoc Member Level 
Saturday, June 23, 2012 7:52:19 PM
Re: Bob Stocks post# 23817 Post # of 24440 
Medicare pays for REPR's product and rejects everybody else's. The "upgrade" pumps are electronic and multitudes more expensive which is probably why REPR's sales are exploding.

It is more unique than a snowflake. You have less of a clue what you're talking about than you had with ALIF when we went at it, and you were loading up 1.30+ screaming your head off that their massive accounts receivable problem was fine, stalking me to all sorts of other boards, and now is down 97%.

http://investorshub.advfn.com/boards/memberpoststoboard.aspx?userid=59646&boardid=12627

But to answer your questions...

1. Subcutaneous can be done easily at home by the patient at his or her lesiure or even while traveling where IV is typical done at a hospital or by an at home-nurse. It's always massively more expensive and inconvenient.

2. The ratio of people dropping IV and going to SC is accelerating rapidly and as been, due to #1.

3. The cost savings are far better with SC than IV.

Like I said, it's innovative, unqiue, and I don't have to "pump" it up. They are doing awesome by their own merits. I doubt you'd short it after you went dead broke on ALIF.


Raw

Research & analysis on some of my favorite stocks is located on the sticky note on the SwingTrade board.

http://investorshub.advfn.com/boards/board.aspx?board_id=1781
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist